Adma Biologics (ADMA) Leases (2016 - 2025)
Historic Leases for Adma Biologics (ADMA) over the last 10 years, with Q3 2025 value amounting to $9.3 million.
- Adma Biologics' Leases rose 420.37% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 420.37%. This contributed to the annual value of $8.6 million for FY2024, which is 1038.92% down from last year.
- Per Adma Biologics' latest filing, its Leases stood at $9.3 million for Q3 2025, which was up 420.37% from $9.0 million recorded in Q2 2025.
- Over the past 5 years, Adma Biologics' Leases peaked at $10.6 million during Q2 2022, and registered a low of $6.2 million during Q1 2021.
- Over the past 5 years, Adma Biologics' median Leases value was $9.2 million (recorded in 2024), while the average stood at $8.8 million.
- In the last 5 years, Adma Biologics' Leases soared by 14042.31% in 2021 and then tumbled by 1465.36% in 2025.
- Over the past 5 years, Adma Biologics' Leases (Quarter) stood at $7.3 million in 2021, then skyrocketed by 44.37% to $10.5 million in 2022, then decreased by 8.11% to $9.6 million in 2023, then decreased by 10.39% to $8.6 million in 2024, then increased by 7.38% to $9.3 million in 2025.
- Its Leases stands at $9.3 million for Q3 2025, versus $9.0 million for Q2 2025 and $8.0 million for Q1 2025.